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Abstract
Reactive oxygen species (ROS) are emerging as important regula-
tors of cancer growth and metastatic spread. However, how cells
integrate redox signals to affect cancer progression is not fully
understood. Mitochondria are cellular redox hubs, which are
highly regulated by interactions with neighboring organelles.
Here, we investigated how ROS at the endoplasmic reticulum
(ER)–mitochondria interface are generated and translated to
affect melanoma outcome. We show that TMX1 and TMX3
oxidoreductases, which promote ER–mitochondria communica-
tion, are upregulated in melanoma cells and patient samples.
TMX knockdown altered mitochondrial organization, enhanced
bioenergetics, and elevated mitochondrial- and NOX4-derived
ROS. The TMX-knockdown-induced oxidative stress suppressed
melanoma proliferation, migration, and xenograft tumor growth
by inhibiting NFAT1. Furthermore, we identified NFAT1-positive
and NFAT1-negative melanoma subgroups, wherein NFAT1 expres-
sion correlates with melanoma stage and metastatic potential.
Integrative bioinformatics revealed that genes coding for mito-
chondrial- and redox-related proteins are under NFAT1 control
and indicated that TMX1, TMX3, and NFAT1 are associated with
poor disease outcome. Our study unravels a novel redox-
controlled ER–mitochondria–NFAT1 signaling loop that regulates
melanoma pathobiology and provides biomarkers indicative of
aggressive disease.
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Introduction
Cancer cells’ redox state is emerging as an important factor in
carcinogenesis, tumor cell aggressive behavior, metabolism, and
drug resistance (Chio & Tuveson, 2017). Abnormal reactive oxygen
species (ROS) levels in transformed cells can be attributed to
changes in organelle dynamics, an inefficient mitochondrial respi-
ratory chain, increased metabolic needs, altered ROS scavenging,
and oncogene-induced stress (Weinberg & Chandel, 2009; Sabhar-
wal & Schumacker, 2014; Willems et al, 2015; Idelchik et al,
2017). At the center of it all, ER and mitochondria, via precise
contact sites, play the essential role of coordinating redox, but also
calcium (Ca2+) and lipid signaling (Elbaz & Schuldiner, 2011;
Rowland & Voeltz, 2012; Booth et al, 2016; Pedriali et al, 2017).
Accordingly, alterations in organelle structure and inter-organelle
contacts can have profound implications for redox signaling and,
hence, tumor cell behavior. However, how cells react or adapt to
these alterations, how these are integrated with other signaling
inputs, and how we can use this knowledge for therapeutic or
diagnostic purposes require further understanding (Gorrini et al,
2013; Panieri & Santoro, 2016; Chio & Tuveson, 2017; Hempel &
Trebak, 2017).
Melanoma, the deadliest of skin cancers, is highly reliant
on mitochondrial activity and ROS signaling for its resilience
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(Haq et al, 2013; Roesch et al, 2013; Vazquez et al, 2013). A
recent study showed that healthy tissues have consistent mito-
chondrial morphology and organization as well as protein expres-
sion, while those patterns disappear in skin cancer (Pouli et al,
2016). At the molecular level, we have shown that tumor-main-
taining and multidrug-resistant melanoma cells (displaying high
levels of the histone demethylase JARID1B) have higher mito-
chondrial energy production, consume more oxygen, and gener-
ate higher amounts of ROS compared to drug-sensitive cells
(Roesch et al, 2013). Meanwhile, the transcription factor peroxi-
some proliferator-activated receptor gamma coactivator 1alpha
(PGC1a) defines a subset of oxidative stress-resistant melanoma
cells featuring increased mitochondrial capacity (Haq et al, 2013;
Vazquez et al, 2013). Recent studies also suggest that antioxi-
dants (some targeted to the mitochondria) promote distant metas-
tasis in melanoma and lung cancer (Sayin et al, 2014; Le Gal
et al, 2015; Piskounova et al, 2015). Confirming this, specific
pharmacological targeting of the antioxidant enzyme thioredoxin
reductase 1 efficiently eliminated a panel of cancer cells (Stafford
et al, 2018).
Recent findings demonstrated that the thioredoxin-related
transmembrane proteins 1 and 3 (TMX1 and TMX3) are enriched
in the mitochondria-associated membranes (MAMs) of the ER
(Lynes et al, 2012; Raturi et al, 2016). In a separate study, TMX1,
TMX3, and the related TXNDC15 were identified as regulators of
the nuclear factor of activated T cells (NFAT1) through a whole-
genome siRNA screen (Sharma et al, 2013). NFAT1 belongs to
the NFAT family of transcription factors and is essential for
controlling the immune system and the function of other organ
systems. Under resting conditions, NFAT proteins are phosphory-
lated and reside in the cytosol; in activated cells, NFAT1 is
dephosphorylated by the calcineurin phosphatase, a process
which is controlled by intracellular Ca2+. Thus, the store-operated
Ca2+ entry (SOCE) through the STIM-gated ORAI channels is a
major regulator of the NFAT1-governed gene transcription (Shaw
et al, 1988; Rao et al, 1997; Kar & Parekh, 2015). As a major
Ca2+ entry pathway in non-excitable cells, SOCE is also impli-
cated in the regulation of important cancer-based processes (Pre-
varskaya et al, 2011; Prakriya & Lewis, 2015; Hoth, 2016). We
and others have shown that SOCE regulates melanoma growth
and metastatic spread (Stanisz et al, 2014, 2016; Hooper et al,
2015). Moreover, the NFAT family was reported to play an
important role in melanoma and other cancers (Flockhart et al,
2009; Mancini & Toker, 2009; Muller & Rao, 2010; Perotti et al,
2012; Shoshan et al, 2016). These studies collectively suggested
that TMX, mitochondrial activity, and NFAT1 signaling cooperate
to control cancer biology.
In this study, we first examined the expression and abundance
of TMX1, TMX3, and NFAT1 in healthy vs. cancer tissues. We
investigated how disrupting ER–mitochondria communication by
TMX downregulation affected cellular redox processes, with impli-
cations on signaling activity via the monitoring of NFAT1 translo-
cation. We then showed that TMX1, TMX3, and NFAT1
contribute to melanoma proliferation and migration in vitro and
in vivo. We finally analyzed their roles in patient survival and
propose a model whereby redox signals at ER–mitochondria inter-
face emerge as important regulators of melanoma aggressive
behavior.
Results
TMX1, TMX3, and NFAT1 expression is elevated in melanoma
Because melanoma is heterogeneous genetically and in its clinical
manifestation, we investigated TMX and NFAT expression patterns
across multiple human melanoma cell lines. As shown in Fig 1A,
TMX1 mRNA levels were heterogeneous; however, in more than 70%
of the lines tested, they reached higher levels than that observed for
healthy melanocytes. Higher expression patterns were also observed
for TMX3, suggesting a non-trivial role for the TMX family in mela-
noma (Fig EV1A). Quantitative PCR (qPCR)-based screening of all five
NFAT isoforms in melanoma cell lines indicated that all NFAT
isoforms are detectable, while NFAT1 is predominant (Fig EV1B). We
next compared NFAT1 mRNA expression in our extended panel of
genetically distinct melanoma cell lines and observed that in nine out
of ten melanoma lines, NFAT1 is expressed and is higher compared to
healthy melanocytes and keratinocytes, wherein NFAT1 transcripts
were almost undetectable (Fig 1B). Intriguingly, one melanoma line
(WM1366) was NFAT1-negative, suggesting alternative signaling in
this vertical growth phase (VGP) melanoma cell line. The higher
expression levels of TMX1 and NFAT1 were also confirmed at the
protein level using immunoblot analysis (Fig 1C).
To explore the clinical relevance of TMX1 and NFAT1, we
analyzed their abundance in samples from human melanoma
patients compared to normal human skin using immunohistochem-
istry (IHC). In Fig 1D, we examined TMX1 and NFAT1 expression
in healthy skin melanocytes (panels 1, 4, and 7, left) and in a mela-
noma lesion (panels 1, 4, and 7, right) of a patient diagnosed with
nodular melanoma (tumor thickness ≥ 4 mm). Figure 1D shows
that melanocytes, positive for Melan-A (panels 1 and 2, brown stain-
ing; see arrows), express moderate levels of TMX1 (panels 4 and 5,
red-brown staining). The images shown in panels 7 and 8 indicate
that NFAT1 is not expressed in the melanocytes within the basal
epidermal layer nor in the epidermal keratinocytes. Our IHC analy-
sis also shows that melanoma cells are positive for Melan-A (panel
3, brown staining) as well as for TMX1 (panel 6, red-brown stain-
ing) and NFAT1 (panel 9, deep red staining). A similar pattern of
expression for Melan-A, TMX1, and NFAT1 is found in a second
patient with nodular melanoma (Fig EV1C; tumor thickness
≥ 4 mm). To test if the expression patterns of TMX1 and NFAT1
correlate with melanoma stage, we performed IHC to compare their
abundance in progressively aggressive tissues. Our samples featured
healthy skin, a nevus, melanoma in situ, melanoma patient samples
with tumor thickness lower than 2 mm (less aggressive), samples
with thickness higher than 4 mm (more aggressive), and metastatic
melanoma (highly aggressive). The images in Fig 1E indicate that
TMX1 (red-brown staining) abundance starts to increase in mela-
noma in situ [patients 3 and 4 (P3 and P4)] and remains relatively
high in the more aggressive melanoma stages (P5–P13). On the
other hand, NFAT1 is absent in healthy skin and melanocytic nevi
as well as in melanoma in situ and two out of three melanomas with
thickness lower than 2 mm (P1–P6). One melanoma with thickness
lower than 2 mm was positive for NFAT1 (deep red staining) as
well as the samples from the more aggressive melanoma stages (P7–
P13). These findings confirmed the expression analysis obtained
from the melanoma cell line panel and suggested that melanoma
aggressiveness correlates with TMX1 and NFAT1 expression levels.
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Figure 1. TMX1 and NFAT1 expression is elevated in human melanoma cell lines and patient samples.
A, B mRNA levels of TMX1 (A) and NFAT1 (B) in primary melanocytes, keratinocytes, and melanoma cell lines.
C Representative immunoblot (from 3) depicting protein abundance of TMX1 and NFAT1 in melanocytes and melanoma cell lines; actin was used as a loading
control. Indicated band intensities were normalized to actin, and background signal was subtracted.
D Melan-A (brown), TMX1 (red-brown), and NFAT1 (deep red) staining (IHC) in a primary stage 4 high-risk nodular melanoma patient I (out of four); the enlarged
regions show healthy tissue (panels 2, 5, and 8) and tumor tissue (panels 3, 6, and 9). Arrows indicate Melan-A-positive melanocytes.
E TMX1 (red-brown) and NFAT1 (deep red) staining of healthy human skin and increasing melanoma stages; P1–P13 refer to the donor patient number.
Data information: In (D, E), scale bar: 50 lm. In (A, B), data are normalized to the expression of TBP and are presented as mean  SEM (n ≥ 3). Statistical significance
was addressed using unpaired, two-tailed Student’s t-test, *P < 0.05; **P < 0.01; ***P < 0.005.
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In an additional set of patient samples, we tested the expression of
TMX1 based on melanoma staging (Fig EV1D), which confirmed
our findings regarding the high expression of TMX1 in increasingly
aggressive melanomas. Collectively, our diverse cell line and patient
data depicted in Figs 1 and EV1 show a frequent and significant
increase in TMX1, TMX3, and NFAT1 expression in melanoma,
which correlates with disease stage.
NFAT1 nuclear translocation is impaired in TMX-silenced
melanoma cells
Given that the interplay between TMX1, TMX3, and NFAT1 in mela-
noma has not been investigated so far and was only indirectly
suggested by a whole-genome siRNA screen (Sharma et al, 2013),
we explored their connection in more detail. Therefore, we used a
GFP-tagged NFAT1 construct to track its nuclear translocation, using
time-lapse fluorescence microscopy. We monitored NFAT1 nuclear
translocation in WM3734 melanoma cells following stimulation with
insulin (50 lg/ml), which induces SOCE (Fig 2A and B). The data
indicate that physiologically, melanoma cells readily respond to
SOCE with NFAT1 translocation to the nucleus. Next, we silenced
TMX1 or TMX3 and monitored NFAT1 translocation in two mela-
noma cell lines. To obtain a more robust readout, we henceforth
used the SERCA pump inhibitor, thapsigargin (Tg, 1 lM), which
activates SOCE by passively depleting the ER Ca2+ stores (Lytton
et al, 1991). Due to the high expression of TMX1, TMX3, and
NFAT1, we selected WM3734 as a primary cell line for this study.
The second line chosen was Mel Juso, which expresses high levels
of both TMX1 and TMX3 and moderate amounts of NFAT1 (see
Figs 1 and EV1). An additional reason for selecting these cell lines is
to take into account different BRAF mutational backgrounds. To this
end, WM3734 carries the BRAF V600E mutation while the Mel Juso
line is BRAF wild type (WT). Later in the study, we expand the cell
line panel to include 1205Lu, due to their highly aggressive behavior
in animal xenografts, and WM1366, due to their NFAT1-negative
status (see Appendix Table S1 for additional information on the
melanoma cell lines used in this study).
To examine the role of TMX1 and TMX3 in melanoma cells, we
used siRNA (transient, kd) and shRNA (stable, kds) to downregulate
gene expression. Knockdown efficiency was confirmed by immuno-
blots and qPCR analyses (Fig EV2A–I). Figure 2C–E shows that
WM3734 cells silenced for TMX1 (red) or TMX3 (orange) have
reduced NFAT1 nuclear translocation by 30–40%. Similar observa-
tions apply to Mel Juso (Fig 2F–H), WM1366 (Fig EV2J and K),
WM983B (Fig EV2L and M), and WM164 (Fig EV2N and O), exam-
ined for their different genetic backgrounds (Appendix Table S1). In
summary, the data shown in Figs 2 and EV2 indicate that NFAT1
nuclear translocation is influenced by the levels of TMX oxidoreduc-
tases in melanoma cells.
TMX1 silencing does not affect SOCE but increases
ROS production
Because intracellular Ca2+ and SOCE regulate NFAT1 activity, and
we had previously implicated TMX1 in intracellular Ca2+ signaling
(Raturi et al, 2016), we measured cytosolic Ca2+ dynamics in TMX-
silenced WM3734 cells using two different protocols and two dif-
ferent sensors (Figs 3A–E and EV3A–C). Cells were treated with Tg
in order to induce Ca2+ release from the ER and thus initiate STIM/
ORAI-mediated Ca2+ entry across the plasma membrane (PM). The
data shown in Figs 3A–E and EV3A–C display no overt effects of
TMX silencing on SOCE in melanoma cells. These results suggested
that alterations in TMX expression control NFAT1 translocation
through an alternative molecular mechanism.
TMXs are oxidoreductases found in the ER MAM domains and
can thus influence the cellular redox state by affecting ER–mito-
chondria interactions. Hence, we next investigated the cellular ROS
levels following TMX silencing. For this purpose, we used the genet-
ically encoded protein sensor HyPer to measure overall H2O2 levels
(Bilan et al, 2013; Gibhardt et al, 2016). Our data show a significant
increase in cellular H2O2 levels in the TMX1 (red)- and TMX3
(orange)-silenced WM3734 and Mel Juso melanoma cells (Fig 3F–
H). To exclude the effects of pH from our results, we used the
control SypHer sensor, which is a redox-insensitive but pH-sensitive
form of HyPer (HyPer-C199S; Poburko et al, 2011). Figure EV3D
and E shows that cellular pH is not altered following TMX silencing.
In addition, TMX1 silencing caused a moderate, but significant,
increase in H2O2 levels in the NFAT1-negative WM1366 cells, with
no effect on the cellular pH (Fig EV3F and G). To evaluate the effect
of Ca2+-store depletion on cellular redox state, we quantified H2O2
levels upon stimulation with Tg. Figure EV3H demonstrates that
acute Tg stimulation has no significant effect on the cellular H2O2
production (see Tg arrow).
Our findings point toward an important role for TMX oxidoreduc-
tases as regulators of cellular redox state. To test this hypothesis,
we measured H2O2 levels in a number of genetically distinct mela-
noma cells and correlated these values with TMX1 mRNA levels.
Figure EV3I and J demonstrates a strong correlation between TMX1
expression levels and the resting H2O2 levels.
Summarizing, we show that TMX1 and TMX3 are important
regulators of the cellular redox state; TMX downregulation leads to
an increase in cellular ROS levels in NFAT1-positive as well as in
NFAT1-negative melanoma cells.
ROS inhibit NFAT1 via oxidation of calcineurin
We next examined the mechanism behind the inhibition of NFAT1
translocation following TMX knockdown. NFAT1 in its inactive
form resides in the cytosol (Rao et al, 1997). Accordingly, we asked
if the increased oxidative environment within the cytosol caused by
altered TMX expression could be responsible for NFAT1 inhibition.
To test this hypothesis, we exposed WM3734 cells overexpressing
NFAT1-GFP to increasing doses of H2O2 and imaged Tg-induced
NFAT1 translocation. Figure 4A demonstrates that H2O2 inhibits
NFAT1 translocation in a concentration-dependent manner. Evalua-
tion of the data revealed an H2O2 IC50 value of approximately 13 lM
for WM3734 cells (Fig 4B). To further examine the oxidant-induced
inhibition of NFAT1, we monitored NFAT1 translocation in TMX1-
silenced WM3734 cells in the absence (red) and presence (light red)
of the antioxidant N-acetyl-L-cysteine (NAC; Fig 4C), PEG-catalase
(a H2O2 scavenger), and dithiothreitol (DTT, a reducing agent).
Figure 4D shows that all agents interfering with oxidative protein
modifications or elimination of ROS reversed the effect of TMX1
silencing on NFAT1. These findings were further confirmed in Mel
Juso cells (Fig EV3K and L). To evaluate the effects of antioxidants
on HyPer oxidation status, we treated the TMX-silenced cells with
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NAC, PEG-catalase, and DTT. Figure EV3M shows that antioxidants
cause the reduction of the HyPer sensor and thus support the role of
H2O2 in the TMX silencing-induced NFAT1 inhibition.
Oxidation can affect NFAT1 translocation by targeting different
proteins involved in NFAT1 signaling, i.e., calmodulin, calcineurin,
or NFAT1 itself. Protein phosphatases are often sensitive and are
inhibited by oxidation (Denu & Tanner, 1998). We therefore focused
on the role of calcineurin in TMX-silenced cells using a genetically
encoded sensor of calcineurin activity (CaNAR2; Mehta et al, 2014).
Our data show that the basal (resting) and the Tg-induced calcineurin
activity are suppressed in TMX-silenced WM3734 melanoma cells
(Fig 4E–G). The responsiveness of CaNAR2 was tested by exposing
melanoma cells overexpressing the sensor to increasing doses of
H2O2; Fig 4H and I display concentration-dependent sensitivity of
CaNAR2 to H2O2. Using an alternative commercially available calci-
neurin activity assay, we confirmed that TMX knockdown inhibits
calcineurin in melanoma cells (Fig EV3N). Similar to the NFAT1






Figure 2. TMX1 or TMX3 silencing impairs NFAT1 nuclear translocation in melanoma cells.
A, B Insulin (50 lg/ml) induced the translocation of NFAT1-GFP to the nucleus of WM3734 cells. (A) Ratio images (F/F0); (B) corresponding endpoint quantification
(n = 5).
C–H Reduced nuclear translocation of NFAT1-GFP in TMX1- or TMX3-silenced (siRNA) melanoma cells. (C) Images show NFAT1-GFP fluorescence intensity before and
after stimulation with thapsigargin (Tg; 1 lM) in WM3734 cells. (D) Corresponding time-dependent nuclear import of NFAT1 as a change of F/F0. (E) Normalized
endpoint quantification. The same analysis was performed with Mel Juso cells with (F) images, (G) time-dependent nuclear import, and (H) normalized endpoint
quantification.
Data information: In (A), (C), and (F), scale bars: 10 lm. In (A), color code: blue = 0, red = 3. In (E) and (H), data are presented as mean  SEM (n values: WM3734,
control = 142, TMX1 kd = 116, TMX3 kd = 148; Mel Juso, control = 75, TMX1 kd = 47, TMX3 kd = 67). Statistical significance was addressed using unpaired, two-tailed
Student’s t-test, *P < 0.05; **P < 0.01.
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calcineurin inhibition (Fig 4J and K). In sum, Fig 4 suggests that
oxidation-induced inhibition of calcineurin activity plays an impor-
tant role in the inhibition of NFAT1 following TMX downregulation.
Mitochondria and NADPH oxidase 4 are sources for ROS
We next wanted to understand how TMX oxidoreductases control
ROS production and therefore NFAT1 nuclear translocation. Given
that TMX oxidoreductases reside in the ER, we examined if TMX
downregulation leads to elevated ROS levels in this organelle. Due
to the highly oxidizing environment within the lumen of the ER,
measurements of ER ROS are difficult; nevertheless, ER-targeted
roGFP and HyPer sensors have successfully been used in the past
(van Lith et al, 2011; Santos et al, 2016). Hence, we overexpressed
HyPer targeted to the ER and measured ER H2O2 in control and






Figure 3. Silencing of TMX1 or TMX3 causes ROS production.
A–C (A) Thapsigargin (Tg)-induced Fura-2-based cytosolic Ca2+ imaging in Ringer’s buffer containing 0.25 mM Ca2+. (B) Quantification of basal cytosolic calcium levels
and (C) SOCE quantification (plateau–basal) for WM3734 after stable silencing of TMX1 (two clones).
D, E (D) Cytosolic Ca2+ imaging (Fura-2) and (E) SOCE quantification (plateau–basal) for WM3734 after transient silencing of TMX1 or TMX3.
F–H Cellular H2O2 (HyPer) was evaluated in two melanoma cell lines upon TMX1 kd and TMX3 kd. (F) Exemplary ratiometric images (F505 nm/F420 nm) are shown for
WM3734 and Mel Juso. Quantification of basal cellular H2O2 in WM3734 (G) and Mel Juso (H) cells.
Data information: In (B, C), data are presented as mean  SEM (n values: WM3734, control = 939, TMX1 kds 1 = 988, TMX1 kds 2 = 508). In (E), data are presented as
mean  SEM (n values: WM3734, control = 30, TMX1 kd = 49, TMX3 kd = 52). In (G, H), data are presented as mean  SEM (n values: WM3734: control = 168, TMX1
kd = 209, TMX3 kd = 192; Mel Juso: control = 297, TMX1 kd = 343, TMX3 kd = 440). Statistical significance was addressed using unpaired, two-tailed Student’s t-test,
**P < 0.01. In (F), scale bars: 10 lm; color code: WM3734: blue = 0, red = 3; Mel Juso: blue = 0, red = 1.5.
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Figure 4. ROS inhibit NFAT1 translocation via oxidation of calcineurin.
A WM3734 cells were pre-incubated for 5 min with extracellular H2O2 (0–500 lM). Tg-stimulated NFAT1-GFP nuclear translocation was measured as F/F0.
B The IC50 of H2O2 inhibition of NFAT1 nuclear import was determined to be 13.2 lM (red mark).
C Tg-induced NFAT1-GFP nuclear import in transient TMX1-silenced WM3734 cells and after pre-incubation with 100 lM N-acetyl-L-cysteine (NAC) for 48 h.
D Endpoint quantification of the data from (C) and upon treatment with NAC, PEG-catalase (50 U/ml), or DTT (1 mM).
E Cytosolic calcineurin activity (CaNAR2) in WM3734 cells with transient knockdown of TMX1 or TMX3 measured upon Tg stimulation.
F, G Quantification of the basal calcineurin activity and the maximal calcineurin activity (plateau–basal).
G Normalized Tg-induced cytosolic calcineurin activity in Mel Juso cells after 5-min pre-incubation with extracellular H2O2 (0–200 lM).
H Quantification of the maximum cytosolic calcineurin activity (plateau–basal).
I Quantification of the basal calcineurin activity and the maximal calcineurin activity (plateau–basal) 8 h after treatment with the antioxidant NAC (100 lM) in
WM3734 with transient knockdown of TMX1.
Data information: In (A, B), data show an average of at least four single cells from one experiment. In (D), data are presented as mean  SEM (n values: control = 73,
control + NAC = 19, TMX1 kd = 57, TMX1 kd + NAC = 63, TMX1 kd + catalase = 58, TMX1 kd + DTT = 22). In (F, G), data are presented as mean  SEM (n values:
control = 49, TMX1 kd = 48, TMX3 kd = 63). In (I), data are presented as boxplots (center line: median; box: 25 and 75% percentile; whiskers: 1.5 times interquartile
range; outliers are shown as dots; n ≥ 20). In (J, K), data are presented as mean  SEM (n values: control = 15, TMX1 kd = 24, TMX1 kd + NAC = 19). Statistical
significance was addressed using unpaired, two-tailed Student’s t-test, *P < 0.05; **P < 0.01; ***P < 0.005.
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significant reduction in the HyPer ratio, suggesting that the majority
of the sensor molecules are in an oxidized state (Fig EV4A).
However, addition of external H2O2 caused a small elevation in the
signal, indicating that ER-HyPer was not fully oxidized (Fig EV4B).
Based on these control experiments, we tested the effects of TMX1
on the ER H2O2 levels and found that TMX1 or TMX3 silencing
causes a slight increase in H2O2 within the ER lumen (Fig EV4C).
Given that elevated ER H2O2 is often connected with disturbed ER
function, we evaluated ER stress by quantifying the splicing product
of X-box binding protein 1 (XBP1s) mRNA levels as well as protein
disulfide isomerase (PDI) and binding immunoglobulin protein
(BiP) abundance in melanoma cells after TMX silencing. The results
shown in Fig EV4D and E indicate no apparent ER stress in TMX-
silenced cells and hint toward an alternative source of ROS within
the ER or its vicinity.
In most cells, mitochondria and NADPH oxidases (NOX) are
major sources of superoxide radicals and thereby H2O2 (Bedard &
Krause, 2007; Murphy, 2009; Bogeski et al, 2011; Holmstrom &
Finkel, 2014). To first explore the role of mitochondria in ROS
production, we expressed HyPer in the mitochondrial matrix of
WM3734 and Mel Juso melanoma cells and observed that TMX
silencing led to an increase in resting mitochondrial H2O2 levels
(Fig 5A–C). To exclude pH effects, we used the control SypHer
sensor (Fig EV4F and G). Mitochondrial oxidative phosphorylation
and thus ROS production are tightly coupled with mitochondrial
Ca2+ signaling (Booth et al, 2016). To assess the role of Ca2+
dynamics on mitochondrial ROS production, we measured mito-
chondrial Ca2+ levels using a genetically encoded Ca2+ sensor
(4mt-D3cpV). We observed that TMX1-silenced WM3734 cells have
increased resting mitochondrial Ca2+ levels as well as increased
mitochondrial Ca2+ uptake following concomitant ER Ca2+-store
depletion and SOCE activation using Tg (Fig 5D–F). To confirm
these findings, we used an alternative genetically encoded mito-
chondrial Ca2+ sensor (4mt-TNXL). Due to the differential Ca2+
sensitivity (Kd value) of the two sensors, the external Ca2+ concen-
tration was elevated from 0.25 to 1 mM Ca2+. Regardless of these
parameters, the resting mitochondrial Ca2+ levels as well as the Tg-
induced Ca2+ uptake were elevated following TMX1 downregulation
(Fig EV4H–J). To dissect this finding in more detail, we asked if
suppression of the mitochondrial Ca2+ uptake by Ca2+ chelators
such as BAPTA-AM would affect the TMX1 silencing-induced mito-
chondrial H2O2 production. Figure EV4K shows that inhibition of
the mitochondrial Ca2+ uptake only partially reversed the TMX
silencing-induced mitochondrial H2O2 production. To test if redox
regulation of the MCU complex (see Petrungaro et al, 2015;
Dong et al, 2017) might play a role, we evaluated the effects of NAC
on mitochondrial Ca2+ in control and TMX1-silenced cells.
Figure EV4L demonstrates no overt effects of this antioxidant on the
TMX1 silencing-induced mitochondrial Ca2+ elevation. Based on
these findings, we next asked if TMX1 silencing might affect the
mitochondrial Ca2+ signaling machinery. For this purpose, we eval-
uated mitochondrial Ca2+ uniporter A and B (MCUa and MCUb)
and mitochondrial sodium calcium lithium exchanger (NCLX)
expression by qPCR and immunoblotting. Figures EV4M and N show
no overt, i.e., consistent, differences in MCUa, MCUb, and NCLX
expression following TMX1 downregulation in WM3734 and
WM1366 cells. Collectively, these data indicated that elevated mito-
chondrial Ca2+ plays a role but is not the only cause for enhanced
ROS production following TMX downregulation. To identify alterna-
tive causes that lead to elevated mitochondrial ROS in TMX1-
silenced cells, we examined mitochondrial morphology, dynamics,
and intracellular positioning using 3D confocal fluorescence micro-
scopy. Our findings indicate that disturbing the ER–mitochondria
communication through TMX1 downregulation increases mitochon-
drial surface and volume (Fig 5G and H). Moreover, by calculating
the area occupied by mitochondria within the plasma membrane
periphery, we observed a significant increase in mitochondria in the
vicinity of the PM in the TMX1 knockdown WM3734 cells (see
Figs 5I and J, and 9A–E for details). In addition, electron microscopy
of 1205Lu melanoma cells confirmed and expanded these findings
by demonstrating that downregulation of TMX1 leads to reduced
distances between mitochondria and the PM, shorter MAMs, and
larger distances between mitochondria and the ER (Fig 5K–N). In
addition, electron microscopy of HeLa cells confirmed the role of
TMX1 in altering mitochondrial morphology and mitochondrial posi-
tioning relative to the ER and PM (Fig EV4O and P). Collectively, the
data in Fig 5A–N indicate that interference with ER–mitochondria
communication through TMX1 downregulation induces elevated
ROS production through mitochondrial Ca2+ overload and via alter-
ations in mitochondrial morphology and a shift of their intracellular
positioning into the proximity of the plasma membrane.
An alternative source of ROS, and thereby H2O2, within cells are
the NADPH oxidases. NADPH oxidase 4 (NOX4) is highly upregu-
lated in melanoma and absent in healthy skin (Yamaura et al, 2009;
Meitzler et al, 2017) and the interaction between TMX proteins and
NOX4 was previously reported, proposing the presence of NOX4
within the MAM domains (Prior et al, 2016). Hence, we examined
the impact of NOX4 on cellular ROS production in TMX1-silenced
cells with the H2O2 sensor HyPer. As shown before (see Figs 3 and
EV3), cellular ROS levels were elevated in TMX1-silenced cells. This
increase is mitigated if NOX4 expression is silenced or if protein
function is suppressed with the NOX4 inhibitor GKT137831 (Fig 5O
and P); pH changes do not contribute as shown with the control
sensor SypHer (Fig EV4Q).
Summarizing, our data suggest two sources for elevated ROS
upon TMX1 knockdown: first, the mitochondria through elevated
Ca2+ and altered morphology, positioning, and architecture; and
second, the ER via enhanced NOX4 activity.
TMX1, TMX3, and NFAT1 affect melanoma aggressive behavior
To investigate the functional relevance of the TMX–ROS–NFAT1 axis
on melanoma cell behavior, we examined the role of TMX1, TMX3,
and NFAT1 in proliferation and migration. As shown in Fig 6A, cell
proliferation was significantly decreased in the two TMX1 (red)- or
TMX3 (orange)-silenced melanoma cell lines. Consistent with these
data, long-term knockdown of TMX1 using two different shRNAs in
two different melanoma cell lines showed a comparable inhibition in
proliferation (Fig 6B). These findings suggested a contribution of
TMX1 and TMX3 to aggressive cancer cell behavior and supported
the patient data shown in Figs 1 and EV1.
We next suppressed NFAT1 expression to examine if targeting
downstream of TMX1 causes similar results. Figure 6C shows that
NFAT1 silencing reduces the proliferation of the two melanoma cell
lines tested. Furthermore, we treated two melanoma lines with
dipyridamole, a drug that prevents NFAT1–calcineurin interaction,
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Figure 5. TMX1 silencing causes elevated ROS via mitochondria and NADPH oxidase 4.
A–C Mitochondrial H2O2 (mito-HyPer) was measured in two cell lines upon transient TMX knockdown. Exemplary ratiometric images (F505 nm/F420 nm) are shown (A);
corresponding quantification for (B) WM3734 and (C) Mel Juso.
D–F Mitochondrial Ca2+ uptake in WM3734 with stable TMX1 knockdown was measured using a mitochondria-targeted calcium sensor (4mt-D3cpV) (D). Cells were
exposed to 0.25 mM Ca2+ containing Ringer’s buffer and Tg. (E) Quantification of basal mitochondrial Ca2+ levels and (F) mitochondrial Ca2+ uptake (basal–
plateau).
G, H Mitochondrial volume was determined using MitoTracker Deep Red in WM3734 cells with stable knockdown of TMX1. The mean mitochondrial volume was
modeled based on microscopy, and the quantification of mean volume (lm3) and mean surface (lm2) is depicted in (G) and (H), respectively.
I, J Peripheral mitochondria were quantified in WM3734 cells with stable knockdown of TMX1. A peripheral mask was applied based on the membrane staining
(CellMask Green), and mitochondria covered area (MitoTracker Deep Red) was evaluated (see Fig 9). Representative images (I) and quantification (J).
K–N Representative electron micrographs of control and 1205Lu cells with stable TMX1 knockdown (K). Corresponding quantification of the distance between (L)
mitochondria and the plasma membrane, (M) mitochondria and the ER, and (N) the length of the MAM (mitochondria–ER contact site).
O, P Cellular H2O2 concentration (HyPer) 48 h after transient silencing of TMX1 and/or NOX4 in WM3734 cells or after inhibiting NOX4 with GKT137831 (140 nM) (O)
Representative ratiometric images (F505 nm/F420 nm) and (P) quantification.
Data information: In (B, C), data are presented as mean  SEM (n values: WM3734: control = 546, TMX1 kd = 510, TMX3 kd = 621; Mel Juso: control = 416, TMX1
kd = 418, TMX3 kd = 442). In (E, F), data are presented as mean  SEM (n values: control = 62, TMX1 kds = 45). In (G, H), data are presented as boxplots (n values:
control = 101, TMX1 kds = 90; center line: median; box: 25 and 75% percentile; whiskers: 1.5 times interquartile range; outliers are shown as dots). In (J), data are
presented as mean  SEM (n values: control = 163, TMX1 kds = 116). In (L), data are presented as mean  SEM (n values: control = 100, TMX1 kds = 100). In (M, N),
data are presented as mean  SEM (n values: control = 60, TMX1 kds = 60). In (P), data are presented as mean  SEM (n values: control = 837, TMX1 kd = 888, TMX1
kd + NOX4 kd = 793, TMX1 kd + GKT = 844). Statistical significance was addressed using unpaired, two-tailed Student’s t-test, *P < 0.05; **P < 0.01; ***P < 0.005. Scale
bars in (A, I, and O): 10 lm; and (K): 1 lm. Color code in (A) WM3734: blue = 0, red = 6; Mel Juso: blue = 0, red = 12; (O): blue = 0, red = 4.
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Figure 6. TMX1, TMX3, and NFAT1 control melanoma proliferation and invasion.
A Proliferation (48 h) of melanoma cell lines measured after transient knockdown of TMX1 or TMX3.
B Proliferation (48 h) of melanoma cell lines with stable TMX1 knockdown (two clones).
C Proliferation (24 h) of melanoma cell lines after transient knockdown of NFAT1.
D Proliferation of WM3734 48 h after transient knockdown of TMX1 and treatment with NAC (100 lM) or mTEMPO (100 nM).
E Transwell migration (48 h) of WM3734 after transient knockdown of TMX1 or TMX3.
F Transwell migration (48 h) of WM3734 after transient knockdown of TMX1 and treatment with NAC (100 lM) or mTEMPO (1 lM).
G Transwell migration (48 h) of melanoma cell lines after preventing NFAT–calcineurin interaction with dipyridamole (40 lM) or inhibition of calcineurin with
cyclosporine A (CsA, 2 lM).
H Invasion of WM3734 with stable TMX1 knockdown (two clones) through Matrigel for 96 h.
I–K Mouse xenograft model to assess tumor growth of WM3734 with stable TMX1 knockdown (TMX1 kds; two clones) in immunodeficient mice. (I) Tumor growth in the
first 19 days after injection; (J) the corresponding tumor volume quantified after 19 days and (K) after 45 days.
Data information: In (A–G), data are presented as mean  SEM (n = 3). In (H), data are presented as mean  SEM (n = 2). In (I–K), data are presented as mean  SEM
from seven animals for each group. Statistical significance was addressed using unpaired, two-tailed Student’s t-test, *P < 0.05; **P < 0.01; ***P < 0.005.
10 of 22 The EMBO Journal 38: e100871 | 2019 ª 2019 The Authors
The EMBO Journal Xin Zhang et al
and observed a concentration-dependent reduction in melanoma
cell growth (Fig EV5A). Figures 6A–C and EV5A suggest that TMX1,
TMX3, and NFAT1 promote melanoma proliferation. To investigate
the role of ROS in the TMX silencing-induced inhibition of mela-
noma cell proliferation, we treated the knockdown cells with NAC
and mitochondria-targeted mTEMPO. The results presented in
Fig 6D show that antioxidants reverse the “negative” effect of TMX
silencing on melanoma cell growth and thus support the central role
of ROS in the TMX-mediated control of melanoma behavior. Next,
we assessed how TMX1, TMX3, and NFAT1 affect melanoma cell
migration. Figure 6E shows that silencing of TMX1 or TMX3 reduces
melanoma cell migration potential. Similar as for the proliferation
data, antioxidant treatment abrogated the “negative” effects of TMX
silencing on melanoma’s migration potential (Fig 6F). Moreover,
inhibition of the calcineurin–NFAT interaction by dipyridamole as
well as calcineurin inhibition by cyclosporine A suppressed the
migration of two melanoma cell lines (WM3734 and 1205Lu;
Fig 6G). To compare the role of TMX oxidoreductases in NFAT1-
positive and NFAT1-negative melanoma cells, we silenced TMX1
and TMX3 in WM1366 cells and evaluated cell proliferation and
migration as performed in WM3734 and Mel Juso. As shown in
Fig EV5B, TMX1 or TMX3 silencing caused a reduction in WM1366
cell growth. However, when compared with WM3734 and Mel Juso
cells, this effect was less pronounced (10% vs. 19% and 21% for
TMX1, and 7% vs. 29% and 39% for TMX3, respectively). The inhi-
bitory effect of TMX silencing on cell migration was less evident in
the WM1366 cells (Fig EV5C), supporting the functional importance
of NFAT1 in melanoma cell aggressive behavior. To further explore
the role of TMX oxidoreductases in melanoma invasion, we used
transwell Matrigel-based invasion assays. The data shown in Fig 6H
indicate that TMX1 downregulation inhibits not only WM3734
migration but also invasion potential.
To investigate the role of TMX1 in vivo, we injected control and
stable TMX1-downregulated WM3734 cells (using two different
clones) in NOD.Cg-Prkdcscid Il2rgtm1WjI/SzJ (NSG) mice. Confirma-
tion of TMX1 knockdown in the tumor samples is shown in
Fig EV5D. In the first three weeks following s.c. injection, we
observed a decrease in tumor growth in the TMX1 knockdown
groups, which corresponded with the effects seen in vitro (Fig 6I
and J). This effect was no longer present by the end of the experi-
ment as shown in Fig 6K. These results suggested that the cells were
initially inhibited by TMX1 knockdown but were able to adapt
in vivo over a longer period.
Many parameters such as nutrient supply, antioxidative
systems, and oxygen availability could affect bioenergetics, meta-
bolism as well as redox and Ca2+ signaling differently in vitro and
in vivo. Figure EV5E and F shows that phosphorylated AKT
(Ser473) is upregulated in many tumors lacking TMX1 vs. control,
but not in TMX1-silenced cells grown under standard 2D culture
conditions. These data agree with the important role of ROS in
regulating the phosphatidylinositide 3-kinase (PI3K) pathway and
highlight one adaptation mechanism employed by melanoma cells
to offset TMX expression changes in vivo (Robey & Hay, 2009;
Villanueva et al, 2010; Cho et al, 2015). Other long-term adaptive
mechanisms upon TMX silencing could be changes in metabolism
and energy handling. To examine this possibility, we measured
mitochondrial respiration in stable TMX1-silenced WM3734 cells
(two clones) using a Seahorse analyzer. The data shown in
Fig EV5G–I indicate that long-term downregulation of TMX1 leads
to an increase in basal mitochondrial oxygen consumption in the
NFAT1-positive WM3734 cells. Oligomycin treatment showed a
robust inhibition of respiration (respiratory control) while uncou-
pling using FCCP yielded a maximal respiratory rate, which is
increased in TMX1-silenced cells (Fig EV5G–I). Collectively, the
data presented in this figure indicate that the TMX–ROS–NFAT1
signaling axis favors melanoma cell behavior toward a more
proliferative and invasive phenotype.
NFAT1 regulates tumor-associated genes and along with TMXs
affects disease outcome
To confirm our functional data and to address the clinical impor-
tance of TMX1, TMX3, and NFAT1, we analyzed the relationship
between their individual expression levels and disease outcome in
patients with cutaneous melanoma, using The Cancer Genome
Atlas database (TCGA; https://cancergenome.nih.gov/). Our anal-
yses showed that patients with increased TMX1, TMX3, or NFAT1
expression had significantly lower survival expectancy (log-rank
test, P = 0.006, TCGA Skin Cutaneous Melanoma (SKCM) cohort;
Fig 7A). This trend was also apparent when patients were
grouped by high expression of the three genes individually
(Fig EV5J–L).
Besides the discretized expression states, we additionally
assessed the information content of the actual FPKM (fragments per
kilobase million) values of NFAT1, TMX1, and TMX3 by construct-
ing Cox proportional-hazards models (Cox, 1972). In univariate
models, again the discretized state of TMX3 (hazard ratio (HR) 3.09,
95% confidence interval (CI) 1.41–6.77, P < 0.005), but also the
NFAT1 expression (HR 1.02, 95% CI 1.01–1.04, P < 0.05), showed a
significant negative impact on patient survival rates
(Appendix Table S2). Guided by the univariate results and since the
expression of TMX3 and NFAT1 was not correlated in the data
(corr = 0.18), we also constructed a predictive multivariate Cox
model including both significant covariates (likelihood ratio test,
P < 0.005). Both the TMX3 state (HR 2.94, 95% CI 1.33–6.50,
P < 0.01) and the NFAT1 expression (HR 1.02, 95% CI 1.00–1.04,
P < 0.05) independently contributed to the model significantly,
emphasizing the potential use of TMX3 and NFAT1 as prognostic
markers (Appendix Table S3). Cox assumptions were valid for the
model (see Fig EV5M and N).
Around 50% of all cutaneous melanoma patients carry the BRAF
V600E mutation (Schadendorf et al, 2015). Accordingly, we asked if
the BRAF status affects the TMX–NFAT1 axis in melanoma. For this
purpose, we performed bioinformatic analyses on the TCGA mela-
noma patient database. As shown in Appendix Table S4, out of 97
patients, 49 were BRAF WT and 48 were BRAF V600E. We first evalu-
ated the effect of BRAF V600E on NFAT1, TMX1, and TMX3 expres-
sion levels and found that only NFAT1 transcripts were significantly
elevated in patients carrying the BRAF V600E mutation (two-sided
Wilcoxon rank-sum test P = 0.0007) while TMX1 and TMX3
levels were not significantly affected (Fig 7B). To examine the BRAF–
NFAT1 interplay in more detail, we divided the BRAF WT and BRAF
V600E groups into NFAT1-high and NFAT1-low subgroups
(Appendix Table S4). This approach indicated that in the BRAF V600E
group, more patients had high NFAT1 (n_high = 26 vs. n_low = 22)
compared with the WT group (n_high = 15 vs. n_low = 34, Fisher’s
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Figure 7. NFAT1 regulates tumor-associated genes, and with TMX and BRAF, it affects disease outcome.
A Kaplan–Meier survival plots and log rank for the correlation between mRNA expression levels and survival probability of melanoma patients, separated in groups
with high or low expression of any of the three genes of interest (GOI): TMX1, TMX3, and NFAT1. For survival probabilities for the individual genes, please refer to
Fig EV5.
B mRNA expression levels of NFAT1, TMX1, and TMX3 in BRAF WT and BRAF V600E melanoma patients.
C, D Kaplan–Meier survival plots and log rank for the correlation between mRNA expression levels and survival probability of melanoma patients, separated in groups
with (C) BRAF WT and (D) BRAF V600E and with high or low expression of NFAT1.
E Venn diagram showing the respective numbers of differentially expressed genes after NFAT1 knockdown.
F From the differentially expressed genes in (E), mitochondrion-localized and redox-related proteins were more than by chance downregulated after NFAT1
knockdown.
G Differentially expressed genes, categorized by Gene Ontology terms annotations covering established hallmarks of cancer, after NFAT1 knockdown, presented as
fold-enrichment.
Data information: In (A, C, D), shaded areas depict the 95% confidence intervals of the survival probabilities, and significance was assessed using log-rank tests. In (B),
expression levels are based on the FPKM values of the TCGA samples (center line: median; box: 25 and 75% percentile; whiskers: 1.5 times interquartile range). In (F, G),
data are presented as fold-enrichment of the genes affected by knockdown of NFAT1. The significance of the fold change in (F) and (G) was determined with a
hypergeometric test, adjustment by the Benjamini–Hochberg procedure, FDR = 0.05, *adjusted P < 0.05; ***adjusted P < 0.005.
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exact test, P = 0.024). As shown in Fig 7B, neither TMX1 nor TMX3
showed systematic changes in their expression levels when the BRAF
WT and BRAF V600E cohorts were compared. To inspect the clinical
relevance of the NFAT1–BRAF relationship, we evaluated the survival
probability of the patients categorized as NFAT1-high vs. the patients
categorized as NFAT1-low in the BRAFWT population. We found that
the survival probability is significantly reduced (log-rank test
P = 0.0022) in the patients with high NFAT1 when compared with the
patients with low NFAT1 (Fig 7C). We performed the same analysis
in the BRAF V600E patient group and found that in this case, NFAT1
status was not as relevant (Fig 7D). In addition, downregulation of
BRAF in the WM3734 cells did not significantly affect the TMX1
silencing-induced inhibition of NFAT1 nuclear translocation
(Fig EV5O and P). Moreover, the qPCR-based correlational analysis of
the BRAF status and NFAT1, TMX1, and TMX3 expression in the
panel of cell lines used in this study (Fig EV5Q–S) showed a similar
relationship as for the melanoma patients, i.e., increased NFAT1 in
the BRAF V600E cells and unchanged TMX1 and TMX3 (compare to
Fig 7B). Overall, these results display the complexity and intercon-
nected signaling of NFAT1 and BRAF in melanoma. Nevertheless,
within this signaling network, our data clearly showed that the TMX–
ROS–NFAT1 signaling axis is functionally relevant in both BRAF WT
and BRAF V600E melanomas.
Because of the more aggressive phenotype of NFAT1-positive
melanoma cells (see IHC data in Figs 1 and EV1), we set out to iden-
tify genes that are under NFAT1 control in melanoma. For this
purpose, we used differential gene expression datasets from two
independent NFAT1 knockdown studies in melanoma cell lines (for
details, see Shoshan et al, 2016; Aibar et al, 2017). Because the two
studies used different approaches, we first compared their common
up- and downregulated hits and identified 59 genes that were upreg-
ulated and 56 genes that were downregulated following NFAT1
knockdown (Fig 7E and Appendix Table S5). To identify the
NFAT1-controlled signaling pathways and mechanisms, we investi-
gated gene function according to associated annotation data by the
Gene Ontology Consortium (www.geneontology.org). Based on the
distribution of term annotations in the respective background set of
genes, we calculated fold-enrichments for each term per experiment,
as well as the significance of the fold increase (hypergeometric test,
adjustment by the Benjamini–Hochberg procedure, FDR = 0.05). As
shown in Fig 7F and Appendix Table S5, more than by chance of
the genes suppressed following NFAT1 silencing are assigned to the
standard terms “Mitochondrion-localized” (GO:0005739 mitochon-
drion) and “Redox-related” (GO:0016491 oxidoreductase activity,
and GO:0016209 antioxidant activity). These findings suggest that
NFAT1-positive melanoma cells possess mitochondria with higher
bioenergetic capacity and have altered redox state and regulation.
Furthermore, we assessed the transcriptomic data regarding the
“Hallmarks of Cancer” classification and calculated fold-enrichment
in order to identify cancer-related genes under the control of
NFAT1. As shown in Fig 7G and in Appendix Table S5, most of the
genes suppressed following NFAT1 silencing could be assigned to
the hallmark “Deregulating Cellular Energetics”. This analysis also
highlights proliferation- and migration-associated genes, thus con-
firming our experimental findings, which suggested that NFAT1 is a
critical regulator of melanoma cell proliferation and invasion.
Detailed listings of hits, from both experiments and their intersec-
tion, are compiled in Appendix Table S5. In summary, the data
presented in Fig 7E–G reveal that NFAT1-positive melanoma cells
might have altered mitochondrial activity and redox-related proper-
ties. Altogether, our results indicate that TMX1, TMX3, and NFAT1
act as promoters of melanoma disease and can be considered
together as possible prognostic markers in melanoma, indepen-
dently of a tumor’s BRAF mutational status.
Discussion
The role of ER–mitochondria contacts, metabolism, and ROS
in cancer
ER–mitochondria contacts act as regulators of redox, Ca2+, meta-
bolic, and bioenergetic processes; additionally, due to their contri-
bution to multiple aspects of pro-tumorigenic behavior, these
organelles pose interesting targets for anti-cancer therapies (Carde-
nas et al, 2010; Fulda et al, 2010; Clarke et al, 2014; Theodosakis
et al, 2014; Schrepfer & Scorrano, 2016; Zong et al, 2016; Kerkhofs
et al, 2017; Pedriali et al, 2017). Mitochondrial metabolic switches
and ROS production have been proposed to control melanoma drug
and oxidative stress resistance in distinct melanoma subpopulations
(Haq et al, 2013; Roesch et al, 2013; Vazquez et al, 2013). These
studies highlight the important role of mitochondria in cancer
behavior and drug sensitivity, but also raise a number of questions.
For example, how do mitochondria and their contact sites contribute
to cancer progression? How do ER and mitochondria affect cell
outcome and by which signaling mechanisms? Within this study,
we examined how ER–mitochondria communication regulates mela-
noma redox signaling and how this influences melanoma cell
behavior. We selected the TMX oxidoreductases and the transcrip-
tion factor NFAT1 to facilitate our analyses, based on previous stud-
ies suggesting their association (Lynes et al, 2012; Sharma et al,
2013). We first investigated the link between TMX and NFAT1, with
its signaling relevance; then, we examined how TMX-driven ER–
mitochondria changes affect mitochondrial Ca2+ signaling and ROS
production, and finally, we studied the functional relevance of TMX
and NFAT1 for melanoma biology and patient outcome.
TMX and NFAT1 are upregulated in melanoma and they are
functionally linked
Our expression analyses of TMX1, TMX3, and NFAT1 in a panel of
melanoma cell lines and patient samples suggested that the upregu-
lation of these proteins might be associated with a biological advan-
tage for cancer. While our expression observations in melanoma
cell lines and patient tissues may not represent every melanoma
(known for their heterogeneity), they still point to an elevation of
TMX1 as well as to the existence of NFAT1-positive melanoma
subgroups, which are notably predominant among more aggressive
melanomas. These findings are supported by studies showing that
NFAT members play an important role in cancer and that NFAT
isoforms are overexpressed and/or constitutively activated in both
human solid tumors and hematological cancers (Mancini & Toker,
2009; Muller & Rao, 2010; Pan et al, 2013). In melanoma, for exam-
ple, it was reported that targeting NFAT signaling enhanced mela-
noma cell death in oncogenic BRAF V600E cells (Flockhart et al,
2009; Perotti et al, 2012). Accordingly, we examined the link
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between the BRAF mutational status and the TMX–ROS–NFAT1
signaling axis in melanoma cell lines and patient databases. Our
findings suggested that TMX–NFAT1 signaling is functionally rele-
vant not only in BRAF WT but also in BRAF V600E melanomas and
can contribute to melanoma aggressive behavior, in particular in
BRAF WT patients.
Silencing of TMX1 or TMX3 (to interfere with ER–mitochondria
contacts) inhibited NFAT1 translocation in melanoma cells, and
these results are in line with previous findings by another group
(Sharma et al, 2013), which prompted us to originally hypothesize
that TMX1 and TMX3 might affect cytosolic Ca2+ signaling to regu-
late NFAT1 (Crabtree & Olson, 2002). However, TMX knockdown
showed no overt changes in SOCE, so this mechanism could not
explain NFAT1 inhibition.
TMXs can regulate ROS production
TMX downregulation did not affect SOCE, but instead induced
oxidative stress in melanoma cells. Our results showed higher rest-
ing Ca2+ concentration, as well as increased Tg-induced mitochon-
drial Ca2+ uptake. Mitochondria can take up Ca2+ from the ER (via
IP3R and/or via the constitutively active ER Ca
2+ leak channels)
and/or from the cytosol (i.e., via ORAI channels; Bakowski et al,
2012; de Brito & Scorrano, 2008; Hoth et al, 1997). It was shown
that ER–mitochondria positioning can influence contacts between
mitochondria and the PM; additionally, the same study suggested
that the distances between the ER and mitochondria are essential in
shaping mitochondrial Ca2+ dynamics (Csordas et al, 2010). This is
in line with our observations from silencing TMX1, which caused
intracellular mitochondrial repositioning that may expose mitochon-
dria to Ca2+ hotspots close to the plasma membrane and thus cause
elevated mitochondrial Ca2+ levels and increased ROS production.
Additional studies are necessary to decipher how organelle contact
sites govern mitochondrial Ca2+ and ROS dynamics.
TMX1 and TMX3 are enriched in the MAMs, regulating ER–mito-
chondria communication and, thus, mitochondrial function (Lynes
et al, 2012; Raturi et al, 2016). Changes in mitochondrial morphol-
ogy and dynamics could, independently of Ca2+, also explain the
observed elevation in mitochondrial ROS following TMX knock-
down and the increased cellular oxidative stress (Willems et al,
2015).
We could not discount that other sources of ROS were also
adding to the oxidative stress during TMX disruption, such as the
ER lumen or NOX4 (Appenzeller-Herzog et al, 2016). ER stress was
not observed, but our data showed that NOX4, which is upregulated
in melanoma (Yamaura et al, 2009; Meitzler et al, 2017), is also a
key player in ROS production following TMX knockdown. This is in
agreement with a study showing that TMX3 is an interaction partner
for NOX4 (Prior et al, 2016). These findings also indicate that TMX
oxidoreductases serve as suppressors of NOX4 and thereby as cellu-
lar antioxidants, a concept that is in line with the findings reported
in a recent study (Phan et al, 2018).
TMXs protect NFAT1 from oxidative inactivation
Our data also revealed that TMX silencing-induced H2O2 inhibits
NFAT1 translocation via the oxidation of calcineurin, a concept
previously explored but not in melanoma (Wang et al, 1996; Reiter
Figure 8. Schematic of a mitochondria-controlled TMX–ROS–NFAT1 signaling axis in melanoma.
(Left panel) In TMXHIGH cells, the undisturbed ER–mitochondria contacts allow Ca2+ and lipid transfer and thus optimal mitochondrial function. Here, mitochondria and NOX4
generate no or low levels of ROS which can be eliminated by mitochondrial/cellular antioxidants. ORAI channel-governed SOCE activates NFAT1 translocation by its
dephosphorylation through calcineurin and initiates the expression of target genes promoting melanoma proliferation and migration. NFAT1 controls the gene expression of
mitochondrial proteins, thus suggesting a regulatory mitochondria–NFAT1 feedback loop. (Right panel) In TMXLOW cells, ER–mitochondria communication is disturbed,
leading to altered mitochondrial morphology, repositioning close to the PM, elevated mitochondrial Ca2+ uptake, and altered NOX4 activity, thus ultimately causing oxidative
stress. Elevated ROS inhibit NFAT1 activation via oxidation of calcineurin and impair melanoma growth and migration.
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et al, 1999). These findings are supported by our antioxidant results
that reversed this process and indicate that TMX oxidoreductases
promote a less oxidative cell state. Given the broad importance of
calcineurin, in particular in cancer, these findings identified one of
the mechanisms linking TMX knockdown with reduced NFAT1
translocation. Thus, our results suggest that TMX knockdown drives
ROS production (from mitochondria and NOX4), with inhibitory
consequences on calcineurin/NFAT1 signaling. Based on our data,
which show that the basal and the SOCE-induced calcineurin and
NFAT1 activity are suppressed following TMX silencing, it is likely
that the redox regulation of NFAT1 is dominant over its Ca2+-driven
activation.
TMXs and NFAT1 are promoters of aggressive
melanoma phenotypes
It is tempting to propose that keeping mitochondria close to the ER
via high TMX levels ensures controlled metabolism, redox, and
Ca2+ homeostasis, thus facilitating cancer growth and invasion.




Figure 9. Determining mitochondrial positioning using confocal microscopy.
A Schematic workflow for the ImageJ plugin for analysis of peripheral mitochondria.
B Representative cell; top and side views.
C 3D reconstruction of the plasma membrane based on CellMask Green staining.
D Z-stack 5 lm above the coverslip with intracellular peripheral mask.
E Quantification of mitochondria in peripheral mask based on MitoTracker Deep Red staining.
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(2016), who demonstrated an increased dependence of cancer cells
on ER–mitochondria Ca2+ transfer. With this mechanism and our
data in mind, we postulate that high TMX levels keep mitochondria
close to the ER, ROS levels are kept in check, and NFAT signaling is
unimpaired. Conversely, when we reduce TMX expression, we
cause mitochondrial Ca2+ overload and disturb mitochondrial archi-
tecture and function to cause higher ROS production, which ulti-
mately results in oxidative stress and NFAT1 inhibition (proposed
model in Fig 8).
After showing a link between TMX and NFAT1 signaling,
with mitochondrial changes contributing to ROS production and
calcineurin/NFAT1 inactivation, the next step was to confirm the
relevance of these processes to cancer cell behavior and
outcome. TMX1, TMX3, or NFAT1 downregulation caused the
inhibition of melanoma cell proliferation and migration in vitro;
moreover, TMX1 downregulation transiently suppressed mela-
noma tumor growth in xenograft mouse models. The importance
of NFAT1 within this constellation was further supported by the
less aggressive behavior of the NFAT1-negative WM1366 cells, in
which TMX silencing had less dramatic effects on melanoma
pathobiology when compared with the NFAT1-positive melanoma
cells.
The transient nature of the TMX1 inhibition in vivo can be
explained by the compensatory activation of other pathways (ex-
emplified by AKT phosphorylation and changes in bioenergetics;
Fig EV5); compensatory mechanisms are also observed for BRAF
inhibition in melanoma (Villanueva et al, 2013). Alone, our obser-
vations hinted at the pro-tumorigenic contribution of TMX/
NFAT1-driven signaling; this was then further confirmed with our
analyses of the TCGA melanoma patient database (Figs 7 and
EV5). Our investigations showed that elevated levels of either
TMX1, TMX3, or NFAT1 reduced patient survival expectancy.
Additionally, our bioinformatics analyses showed that most of the
NFAT1 target genes code for mitochondrial proteins, for redox-
related proteins (identified as oxidoreductase and antioxidant
activity-related genes), and for tumor promoters. Together, our
data and TCGA analyses suggest the combined TMX/NFAT1 high
expression is indicative of aggressive disease and is of importance
to regulate oxidative stress.
Three seminal studies report that melanoma cell drug resis-
tance and adaptation to oxidative stress are controlled by mito-
chondria; these studies identified PGC1a, MITF, and JARID1B as
regulators of these mitochondria-based resistance mechanisms
(Haq et al, 2013; Roesch et al, 2013; Vazquez et al, 2013). Given
that antioxidants can promote melanoma metastatic spread (Le
Gal et al, 2015; Piskounova et al, 2015) and that inhibition of
antioxidant enzymes can lead to specific elimination of cancer
cells (Stafford et al, 2018), our findings highlight the importance
of better understanding redox-based processes in cancer and the
possibility of using TMX–ROS–NFAT1 signaling for clinical
purposes.
Conclusion
Cancer is a heterogeneous disease where multiple signaling path-
ways, genetic aberrations, and microenvironmental inputs integrate
to determine cell fate. Our findings not only support the importance
of further dissecting ER–mitochondria communication and activity
to understand aggressive tumor cell behavior, but also suggest a
novel pro-melanoma signaling axis linking ER–mitochondria
contacts, bioenergetics, redox regulation, and NFAT1 signaling. We
conclude that the TMX oxidoreductases affect NFAT1 signaling and
contribute to melanoma proliferation and migration and that the
restructuring of ER–mitochondria contacts allows a redox configura-
tion that favors tumor progression. Since TMX1, TMX3, and NFAT1
levels are found elevated in melanoma samples and because they
indicate poor survival outcome, they hold potential as biomarkers
of aggressive disease.
Materials and Methods
Cell culture and reagents
Human melanoma cell lines were previously described (Iliopoulos
et al, 1989; Satyamoorthy et al, 2003) and were a gift from
Meenhard Herlyn (The Wistar Institute, Philadelphia, USA; see
Appendix Table S1). Cellular genotypes and cell line identities
were confirmed by DNA fingerprinting. Melanoma cell lines were
cultivated in TU2% medium (80% MCDB153 basal medium
(Biochrom #F8105), and 20% Leibovitz’s L-15 medium
(Biochrom #F21315) supplemented with 1.68 mM CaCl2 and 2%
FCS), RPMI medium (Fisher Scientific #21875-091) supplemented
with 10% FCS, or DMEM (Fisher Scientific #41966-029) supple-
mented with 10% FCS. HeLa cells were grown in RPMI medium,
supplemented with 10% FCS; HaCat keratinocytes were grown in
DMEM, supplemented with 10% FCS, 1% L-glutamine (200 mM),
and 1% penicillin/streptomycin, and primary melanocytes in M2
Melanocyte Medium (PromoCell #C-24300). All cells were found
negative for mycoplasma and were maintained at 37°C in 5%
CO2. For imaging experiments, cells (150,000–300,000) were
seeded on 25-mm round glass coverslips 24–48 h before transfec-
tion. Genetically encoded protein sensors and NFAT1-GFP
(NFAT1 translocation assay) were transfected using FuGENE
HD (Promega GmbH, Mannheim, Germany) along with 1 lg of
plasmid DNA, according to the manufacturer’s instructions. Imag-
ing was performed 24 h after transfection, unless otherwise
specified.
All chemicals were purchased from Sigma-Aldrich (Munich,
Germany), unless otherwise indicated. The NOX4 inhibitor
GKT137831 was from Cayman Chemical (#17764, USA). Plasmids
used and kindly provided by: NFAT1-GFP (Dr. Rainer Schindl,
Graz, Austria); pcDNA3-cyto-CaNAR2 (Addgene #64729, Jin
Zhang, Baltimore, USA); pcDNA-4mt-D3cpV (Addgene #36324)
and pcDNA3-4mt-TNXL (Addgene #51994, Peter Lipp, Homburg,
Germany); pC1-HyPer3 (Addgene #42131), pC1-HyPer-C199S
(SypHer; Addgene #42213), ER-HyPer (Santos et al, 2016), mito-
HyPer2 (Evrogen #FP942) and mito-SypHer (Addgene #48251, Dr.
Vsevolod V. Belousov, Moscow, Russia); and pcDNA-D3cpV
(Addgene #36323).
Protein knockdown
For transient knockdown, siRNAs from Microsynth were used (Bal-
gach, Switzerland): siTMX1 (50-GAG AAG AUC UUG AGG UUA ATT
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dTdT-30); siTMX3 (50 GGA GUU CGA GGU UAU CCA ATT dTdT-30);
siNFAT-1 (50 CUG AUG AGC GGA UCC UUA A dTdT-30); siNOX4
(50-GUU CUU AAC CUC AAC UGC ATT dTdT-30); and a non-silen-
cing control (50 AGG UAG UGU AAU CGC CUU G dTdT-30). BRAF
siRNA was purchased from Sigma-Aldrich (#EHU127401). Two
million cells and 4 ll of 20 pmol siRNA were used per nucleofection
(Amaxa Nucleofector; Lonza GmbH, Cologne, Germany). All
measurements were performed 48 h after transfection. For stable
downregulation of TMX1, the Sigma MISSION shRNA was used
following the manufacturer’s protocol (SHCLNG-NM_030755;
#TRCN0000338583 and #TRCN0000150291). The shRNAs were
transduced into WM3734, 1205Lu, and WM1366 with a lentiviral
vector (pLKO.1), which was also used as control, and cells were
selected with puromycin (2 lg/ml).
Fura-based Ca2+ imaging
Measurements of cytosolic calcium were performed as in Saul et al
(2016). Briefly, cells were loaded with 1 lM Fura-2 AM (Thermo
Fisher Scientific GmbH, Schwerte, Germany) in growth medium for
30 min at room temperature. The measurements were performed in
Ringer’s buffer (pH 7.4) containing 145 mM NaCl, 4 mM KCI,
10 mM glucose, 10 mM HEPES, 2 mM MgCl2, and concentrations of
CaCl2 as indicated, or in 0 mM CaCl2 with 1 mM EGTA. Time-lapse
ratiometric imaging was performed on an Olympus microscope and
analyzed with TILLVISION software (FEI GmbH, Munich, Germany).
Fluorescence microscopy
Imaging experiments were performed with a Zeiss Cell Observer Z1
equipped with a 40× oil Fluar (N.A. 1.3) objective, multi-filter
system, fast acquisition EMCCD camera (Evolve 512 Delta), and
LED system (Colibri, Zeiss) at 37°C. Data were analyzed with Axio-
Vision software (Zeiss, Oberkochen, Germany).
NFAT1 translocation assay
Cells transfected with NFAT1-GFP were imaged (excitation 490 nm;
emission filter 525  25 nm) in Ringer’s buffer containing 0.25 or
1 mM Ca2+ and stimulated with thapsigargin (1 lM). The increase
in fluorescence intensity in the nucleus was marked with a ROI (re-
gion of interest) and was analyzed by normalizing the background-
corrected fluorescence intensity of F/F0.
Ca2+ measurements
Mitochondrial and cytosolic Ca2+ imaging were performed using the
FRET (fluorescence resonance energy transfer) sensors 4mt-D3cpV
or D3cpV (excitation 420 and 505 nm; emission filters 483  16 nm
and 542  14 nm) in Ringer’s buffer containing 0.25 mM Ca2+ or
1 mM Ca2+. Background and bleed-through were corrected in the
FRET/donor ratio (equation 1).
FRET=Donor Ratio
¼ FRET backgroundð Þ  CFP backgroundð Þ  CF½   YFP backgroundð Þ  CF½ 
CFP backgroundð Þ
(1)
CF: correction factor for YFP or CFP bleed-through
For mitochondrial Ca2+ imaging with 4mt-TNXL (excitation 420 and
505 nm; emission filters 483  16 nm and 542  14 nm), Ringer’s
buffer containing 1 mM Ca2+ was used and the background-
corrected FRET/CFP ratio was analyzed.
Hydrogen peroxide measurements
Cellular, mitochondrial, and ER H2O2 were measured using the
protein sensors HyPer, mito-HyPer, and ER-HyPer, respectively, in
Ringer’s buffer containing 0.25 mM Ca2+ (excitation 420 and
505 nm; emission filter 542  14 nm). For HyPer in Figs 3G and H,
and in EV3F, the H2O2 concentration was set to background levels
by incubating cells with N-acetyl-L-cysteine (100 lM) and subtract-
ing this background ratio value from the experimental data. As a
control to access the pH sensitivity of HyPer, the pH-sensitive but
H2O2-insensitive mutant SypHer (HyPer-C199S) and mito-SypHer
were used to monitor pH in the cytosol and mitochondria, respec-
tively, using the same experimental setting.
Calcineurin activity
The FRET sensor CaNAR2 was used to measure cytosolic calci-
neurin activity (excitation 420 and 505 nm; emission filters
483  16 nm and 542  14 nm). Cells were measured with Ca2+-
free Ringer’s buffer. Ca2+ influx and subsequent activation of calci-
neurin was induced by thapsigargin (1 lM), ionomycin (1 lM), and
Ringer’s buffer containing 1 mM Ca2+. The background-corrected
FRET/CFP ratio was analyzed.
Calcineurin activity assay
The calcineurin cellular activity assay kit (Enzo Life Sciences
#BML-AK816-0001, USA) was used to determine the phosphatase
activity of calcineurin in melanoma cells, using the manufac-
turer’s instructions. Briefly, 2 × 106 cells were collected by
centrifugation and protein was extracted with complete lysis
buffer (Enzo Life Sciences #BML-KI135, USA) for 15 min. Phos-
phatase activity was quantified by detection of free phosphate
released from the reaction by measuring the absorbance of mala-
chite green (OD 630 nm).
Proliferation, migration, and invasion assays
Proliferation was measured with the CellTiter-Blue assay (Promega
GmbH, Mannheim, Germany), according to the manufacturer’s
instructions. In summary, 5,000 cells/well were seeded into 96-well
plates, and after the indicated growth time, CellTiter-Blue was
added and incubated for 3 h prior to fluorescence measurements
using a plate reader (Tecan, Ma¨nnedorf, Switzerland).
Migration was assessed using a transwell migration assay (Corn-
ing, Kennebunk, ME, USA), featuring 8-lm-pore-size inserts. Cells
were seeded 100,000/per well and were stimulated to migrate
toward preconditioned medium supplemented with 10% FCS. Cells
migrated through the membrane were detached with Accutase
after 48 h and quantified using a Moxi Z Mini cell counter (ORFLO
Technologies, Ketchum, USA).
Invasion was measured using the same 8-lm-pore-size inserts,
which were coated with 40 ll of growth factor-reduced Matrigel
(BD MatrigelTM Basement Membrane Matrix, Growth Factor
Reduced; Becton Dickinson, Heidelberg, Germany) diluted 1:2 in
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DMEM. A total of 200,000 cells were made to invade for 96 h
through Matrigel toward medium supplemented with 20% FCS.
Invaded cells were stained with Hoechst 33342 (0.5 lg/ml), imaged
with a Zeiss inverted fluorescence microscope, and quantitated
using ImageJ (NIH, Bethesda, USA).
RT–qPCR
Total isolated RNA (800 ng) was reverse-transcribed to cDNA using
SuperScript II (Thermo Fisher Scientific GmbH, Schwerte,
Germany), and 0.5 ll was used for RT–qPCR using the QuantiTect
SYBR Green Kit (Qiagen #204145) and Bio-Rad CFX96TM Real-Time
System. TBP (TATA box binding protein) was used as a housekeep-
ing gene. Primer sequences used for detection are listed in
Appendix Table S6. Data were analyzed using the 2DCT method.
Immunoblotting
Proteins were extracted as described in Stanisz et al (2014). Briefly,
25 lg (unless otherwise specified) of protein were separated by
10% SDS–polyacrylamide gel electrophoresis and were transferred
onto a nitrocellulose membrane (Amersham Protran Premium
0.45 lm; GE Healthcare #10600003). After transfer, membranes
were blocked in 5% bovine serum albumin prior to primary anti-
body incubation overnight. Antibodies and used dilutions are listed
in Appendix Table S7. Fluorescent secondary antibodies (IRDye; LI-
COR, Lincoln, USA) were incubated for 1 h in the dark, at room
temperature. Membranes were scanned and quantified using an
Odyssey Sa Infrared imaging system (LI-COR, USA).
Determination of mitochondrial volume, surface, and peripheral
mitochondria
Cells were stained with MitoTrackerTM Deep Red FM (100 nM;
Thermo Fisher #M22426) alone or co-stained with CellMaskTM Green
Plasma Membrane Stain (200 nM; Thermo Fisher #C37608) for
10 min at room temperature in cell culture medium and measured
in Ringer’s buffer containing 0.5 mM Ca2+. Z-stacks were acquired
upon 638 nm (mitochondria) and 488 nm (membrane) excitation
with a Nikon Ti-Eclipse spinning disk confocal microscope, 100×
oil-immersion objective (1.44 NA). Mitochondria of individual cells
were modeled with Imaris 9.1 (Bitplane, Zurich, Switzerland), to
obtain the volume and surface on a per-cell basis. Peripheral mito-
chondria were determined using a custom-written macro imple-
mented in the FIJI image processing package (Schindelin et al,
2012) as described in Fig 9. Cell membrane outlines of individual
cells were marked manually in a Z-stack image 5 lm above the
coverslip surface. A peripheral mask of identical thickness was
created, and occupied area was measured based on mitochondrial
staining.
Seahorse analysis
For the determination of respiratory capacity, 100,000 melanoma
cells were seeded into a Seahorse 96-well plate. Cells were prepared
for measurement 3 h after seeding by exchanging medium to
Seahorse XF media supplemented with 1 mM pyruvate and 4.5 g/l
glucose. Oxygen consumption rate (OCR) was measured with a
Seahorse XF96 Extracellular Flux Analyzer (Seahorse Bioscience,
Billerica, MA, USA). Periodic measurements of oxygen consumption
were performed at basal state and after the administration of 3 lM
oligomycin, 1 lM FCCP, and 2 lM rotenone plus 1 lM antimycin A.
Preparation and analysis of electron micrographs
Cell monolayers from control and TMX1 knockdown HeLa and
1205Lu cells were fixed and processed as previously described
(Raturi et al, 2016). Briefly, cells were fixed in 2% paraformalde-
hyde and 2% glutaraldehyde in 100 mM sodium cacodylate buffer
at pH 7.4 for 20 min. Cells were then scraped and pelleted, and then
underwent secondary fixation in osmium tetroxide 1%. Dehydration
of the samples was done after washes and staining in 1% uranyl
acetate. After incubation in propylene oxide, pellets were then
infused with Embed 812 and blocks were hardened at 60°C for a
minimum of 48 h. Images were acquired with “MegaView III” using
a digital camera mounted on a Philips 410 TEM. Mitochondrial
proximity to the plasma membrane was quantified via the coeffi-
cient between the lengths in nm of the contact, divided by the
perimeter of mitochondria times the distance of the contact: Coeffi-
cient = L contact/(perimeter  distance), for the HeLa dataset. For
1205Lu, distance of mitochondria and ER contact and the length of
ER–mitochondria contact sites (MAM length) were measured in nm.
Mitochondrial proximity to the plasma membrane was quantified by
measuring the distance of the closest mitochondria to the plasma
membrane in nm.
Immunohistochemistry
The handling of patient material was performed according to the
Go¨ttingen ethics committee votum No. 13/5/17 and according to the
Statement of the National Ethics Council on Biobanks for Research,
Berlin, Germany. Human melanoma samples were collected only
from patients who signed informed consent. Samples were pseudo-
anonymized, and immunohistochemical staining was performed.
Briefly, 5-lm slides of paraffin-embedded normal skin, primary
melanoma, and metastasis samples were deparaffinated and treated
with target retrieval solution (Dako #S1699) for 20 min. After cool-
ing, endogenous peroxidases were blocked with 3% H2O2, washed
with PBS three times, and stained with primary antibody overnight
in a wet chamber at 4°C (specifics and dilutions are listed in
Appendix Table S7). Samples were afterward washed with PBS
three times. Secondary antibody (goat-anti-mouse Vector #BA-9200,
dilution 1:150; rabbit-anti-goat Vector #BA-5000, dilution 1:150;
goat-anti-rabbit Vector #BA-1000, dilution 1:150) was incubated and
washed exactly as the primary antibody. Samples were blocked with
streptavidin peroxidase (Calbiochem #189733). Photographs were
taken with an Axio Imager M1 and recorded using the AxioVision
software Rel 4.7 (Zeiss, Go¨ttingen, Germany). The slight difference
in staining color (brown-red for TMX1 and deep red for NFAT1) is
due to different secondary antibodies.
In vivo studies
All animal experiments were approved by the local governmental
animal care committee (Landesamt fu¨r Verbraucherschutz des Saar-
landes) and were conducted in accordance with the German
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legislation on protection of animals and the National Institutes of
Health Guide for the Care and Use of Laboratory Animals (NIH
Publication #85–23 Rev. 1985). Male athymic nude NOD.Cg-
Prkdcscid Il2rgtm1WjI/SzJ (NSG) mice (8 weeks old; Charles River
Laboratories, Sulzfeld, Germany) were randomized into three
groups (n = 7 mice/group): (i) shRNA control (control), (ii)
shTMX1_1 (TMX1 kds 1), and (iii) shTMX1_2 (TMX1 kds 2). Mice
were kept in groups in isolated ventilated cages under specific
pathogen-free conditions in a temperature- and humidity-controlled
12-h dark/light environment at the animal care facility of the Insti-
tute for Clinical and Experimental Surgery at Saarland University.
Animals had free access to tap water and standard pellet food, and
their health status was monitored daily. Mice were each inoculated
s.c. with 100,000 WM3734 human melanoma cells in a 1:1 suspen-
sion with Matrigel (BD MatrigelTM Basement Membrane Matrix,
Growth Factor Reduced; Becton Dickinson, Heidelberg, Germany)
and cell media. Tumor growth was measured every 2–3 days by a
single veterinarian blinded to the experimental groups, by means of
a caliper. Volumes were calculated according to the formula
V = (p/6)LW2 [mm3]. Tumor samples (tumors size up to 15 mm
in diameter prior to sacrifice) were fixed and embedded in paraffin
or were snap-frozen in liquid nitrogen for subsequent protein analy-
ses. Immunoblots featuring tumor lysates were conducted as
described in the “Immunoblotting” section, using 25 lg of protein.
Bioinformatics
Significantly deregulated genes from Aibar et al (2017) were
adopted as shown in Appendix Table S5 from the original publica-
tion. Normalized data from Shoshan et al (2016) were downloaded
from NCBI GEO (accession GSE76541), and hits were selected
according to adjusted P-values (Benjamini–Hochberg procedure,
FDR = 0.05). The annotation data were downloaded on 03.22.2018
and included associations inferred from electronic annotation. The
list of genes that are related to established hallmarks of cancer was
compiled by integrating Gene Ontology (Huntley et al, 2015) data as
described in Will and Helms (2016). Additionally, the terms “Mito-
chondrion-localized” (GO:0005739 mitochondrion) and “Redox-
related” (GO:0016491 oxidoreductase activity; GO:0016209 antioxi-
dant activity) were added. The full Aibar et al and Shoshan et al
datasets are available at NCBI GEO under accessions GSM2027644
and GSM2027645 and GSM2644430 and GSM2644431. On the basis
of the distribution of term annotations in the respective background
set of genes, we calculated fold-enrichments for each term per
experiment as well as the significance of the fold increase (hyperge-
ometric test, adjustment by the Benjamini–Hochberg procedure,
FDR = 0.05).
RNA-seq gene expression (FPKM-quantified) and survival data
on Skin Cutaneous Melanoma (SKCM) by TCGA were downloaded
from NIH’s GDC portal on 02.19.2018. Mutation data (MuTect2
aggregated) on the patients were downloaded on 11.29.2018. Only
data on primary tumors and patients with non-negative survival
times were considered. Analogous to Uhlen et al (2017), we
grouped the 102 patients according to low and high expression
states of NFAT1, TMX1, and TMX3, respectively. Corresponding
FPKM thresholds for each gene of interest were derived by scanning
the 20–80% percentiles of the gene’s expression value distribution
and determining an optimal separation in terms of survival based
on the log-rank test. When relevant, the patients were partitioned
into three cohorts given their BRAF genotype: wild type (BRAF
WT), existence of mutation V600E (BRAF V600E), and other muta-
tions. All analyses were conducted using R (version 3.4.3) with the
packages “survival” (version 2.41.3) and “survminer” (version
0.4.2).
Data and statistical analyses
Data obtained from experiments were analyzed or processed using
Zeiss AxioVision, TILLVISION, Bio-Rad Quantity One, ImageJ or
FIJI, and Microsoft Excel. Statistical significance was tested with
unpaired, two-tailed Student’s t-test unless otherwise specified. The
significant differences are indicated by asterisks: *P < 0.05;
**P < 0.01; and ***P < 0.005.
Expanded View for this article is available online.
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